Table 1 Summary of clinical information from each proband.

From: Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

 

Proband 1

Proband 2

Proband 3

Proband 4

Proband 5

Proband 6

 

Human variant

Y336*

Q147Gfs*82

T319Nfs*5

N94Rfs*47

R295P

E306K

Inheritance pattern

De novo

Autosomal dominanta

De novo

Autosomal dominanta

De novo

De novo

Age of onset (y/o)

1 month

0

3

0

0

2 months

 

Current age (y/o)

32

17

8

15 months

11

12

 

Sex

Male

Female

Male

Male

Male

Female

 

Intellectual disability

+

+

NA

+

3/5

Developmental delay

+

+

+

+

+

5/6

Seizures

+

+b

+

+c

4/6

Neurological abnormalities

+

+

+

+

+

+

6/6

Visual disorders

+

+

+

+

4/6

Hearing disorders

+

+

+

3/6

Craniofacial abnormalities

+

+

+

+

+

5/6

Palate abnormalities

+

+

+

3/6

Vertebral abnormalities

+

+

+

+

+

5/6

Scoliosis

+

+

+

3/6

Toe abnormalities

+

+

+

3/6

Connective tissue abnormalities

+

+

+

3/6

Cardiac abnormalities

+

+

+

3/6

Aortic dilation

+

+

2/6

  1. Detailed reports can be found in the Supplemental materials. Proband 2 inherited the variant from her mother who has a milder phenotypic presentation.
  2. aProband 4 inherited his variant from his father, the father did not report any shared phenotypes. It is not known if the mother of proband 2 or father of proband 4 is mosaic.
  3. bFor proband 3 absence seizures were also reported in a sister who did not carry a variant in GDF11.
  4. cFor proband 5 seizures are likely due to Aicardi–Goutières type 6.